Literature DB >> 10837502

Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids.

J M Sullivan1.   

Abstract

Why does smoking marijuana impair learning and memory? Behavioral studies suggest that a disruption of normal hippocampal function contributes to these deficits. In vitro experiments find that cannabinoid receptor activation reduces neurotransmitter release below the levels required to trigger long-term changes in synaptic strength in the hippocampus. Cannabinoids reduce glutamate release through a G-protein-mediated inhibition of the calcium channels responsible for neurotransmitter release from hippocampal neurons. These mechanisms likely play a role in the learning and memory impairments produced by cannabinoids and by endogenous cannabinoid receptor ligands.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837502     DOI: 10.1101/lm.7.3.132

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  50 in total

Review 1.  How might cannabinoids influence sexual behavior?

Authors:  N Stella
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?

Authors:  Stephen A Varvel; Laura E Wise; Aron H Lichtman
Journal:  Drug Dev Res       Date:  2009-12-01       Impact factor: 4.360

3.  Cannabinoid CB(1) receptor-mediated inhibition of hippocampal acetylcholine release is preserved in aged mice.

Authors:  Agnes Redmer; Markus Kathmann; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 4.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

5.  Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.

Authors:  Alexander F Hoffman; Alice M Macgill; Dennison Smith; Murat Oz; Carl R Lupica
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

6.  Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.

Authors:  Alexander F Hoffman; Murat Oz; Ruiqin Yang; Aron H Lichtman; Carl R Lupica
Journal:  Learn Mem       Date:  2007-01-03       Impact factor: 2.460

7.  Developmental alteration of endocannabinoid retrograde signaling in the hippocampus.

Authors:  Ping Jun Zhu; David M Lovinger
Journal:  J Neurophysiol       Date:  2009-12-09       Impact factor: 2.714

Review 8.  The dystrobrevin-binding protein 1 gene: features and networks.

Authors:  A Y Guo; J Sun; B P Riley; D L Thiselton; K S Kendler; Z Zhao
Journal:  Mol Psychiatry       Date:  2008-07-29       Impact factor: 15.992

9.  The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats.

Authors:  Keiichrio Inui; Nobuaki Egashira; Kenichi Mishima; Akiko Yano; Yoshiaki Matsumoto; Nobuyoshi Hasebe; Kohji Abe; Kazuhide Hayakawa; Tomoaki Ikeda; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

10.  The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.

Authors:  Marco Bortolato; Gian Nicola Aru; Roberto Frau; Marco Orrù; Grant Christopher Luckey; Gianluca Boi; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.